Cargando…
The clinical significance of macrolide resistance in pediatric Mycoplasma pneumoniae infection during COVID-19 pandemic
BACKGROUND: Mycoplasma pneumoniae (MP) is a commonly occurring pathogen causing community-acquired pneumonia (CAP) in children. The global prevalence of macrolide-resistant MP (MRMP) infection, especially in Asian regions, is increasing rapidly. However, the prevalence of MRMP and its clinical signi...
Autores principales: | Jiang, Ting-ting, Sun, Lin, Wang, Tian-yi, Qi, Hui, Tang, He, Wang, Ya-cui, Han, Qian, Shi, Xiao-qing, Bi, Jing, Jiao, Wei-wei, Shen, A-dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213390/ https://www.ncbi.nlm.nih.gov/pubmed/37249975 http://dx.doi.org/10.3389/fcimb.2023.1181402 |
Ejemplares similares
-
Increased Macrolide Resistance Rate of M3562 Mycoplasma pneumoniae Correlated With Macrolide Usage and Genotype Shifting
por: Wang, Yacui, et al.
Publicado: (2021) -
Case Report: Omadacycline in the treatment of macrolide-unresponsive Mycoplasma pneumoniae pneumonia in an adolescent patient
por: Xu, Limin, et al.
Publicado: (2023) -
Novel mechanisms of macrolide resistance revealed by in vitro selection and genome analysis in Mycoplasma pneumoniae
por: Wang, Na, et al.
Publicado: (2023) -
Clinical features and “early” corticosteroid treatment outcome of pediatric mycoplasma pneumoniae pneumonia
por: Liu, Jinrong, et al.
Publicado: (2023) -
Pathogenic Analysis of the Bronchoalveolar Lavage Fluid Samples With Pediatric Refractory Mycoplasma pneumoniae Pneumonia
por: Zhao, Fei, et al.
Publicado: (2020)